OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM

por Neri, B., D'Agostini, G., Salvatori, S., Mossa, M., Bettin, F., Marafini, I., Lolli, E., Calabrese, E., Monteleone, G., Biancone, L.
Publicado 2023

Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study

por Neri, B, Pantaleo, P, Giommoni, E, Grifoni, R, Paoletti, C, Rotella, V, Pantalone, D, Taddei, A, Mercatelli, A, Tonelli, P
Publicado 2007

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.

por Neri, B., de Leonardis, V., Romano, S., Andreoli, F., Pernice, L. M., Bruno, L., Borrelli, D., Valeri, A., Fabbroni, S., Intini, C., Cini, G.
Publicado 1996

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

por Neri, B, Cini, G, Andreoli, F, Boffi, B, Francesconi, D, Mazzanti, R, Medi, F, Mercatelli, A, Romano, S, Siliani, L, Tarquini, R, Moretti, R
Publicado 2001

Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study

por Neri, B, Cini, G, Doni, L, Fulignati, C, Turrini, M, Pantalone, D, Mini, E, De Luca Cardillo, C, Fioretto, L M, Ribecco, A S, Moretti, R, Scatizzi, M, Zocchi, G, Quattrone, A
Publicado 2002